StockData
LifeStance Health Group, Inc. logo

LifeStance Health Group, Inc. (LFST) stock

LFSTNasdaqServices-Health ServicesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 12/30143% above fair value
$14.15−0.22 (-1.53%)

Close on Nov 12, 2026Market cap $5.41BP/E 74.5Yield –

Earnings

LifeStance Health's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
Feb 24, 2027
Q4 FY2026 · estimated, after the close
Revenue, Q3 FY2026
$455.90M
+25.3% on a year earlier
EPS, Q3 FY2026
$0.06
$0.00 a year earlier
Latest guidance
Issued
Nov 5, 2026 · 6 items

Quarterly results

Revenue and earnings per share from each of LifeStance Health's earnings releases, newest first

QuarterReportedRevenueYoYEPSSource
Q4 FY2026ended Dec 31, 2026Feb 24, 2027Expected––––
Q3 FY2026ended Sep 30, 2026Nov 5, 2026after the close$455.90M+25.3%$0.06Release
Q2 FY2026ended Jun 30, 2026Aug 6, 2026after the close$435.40M+26.1%$0.06Release
Q1 FY2026ended Mar 31, 2026May 7, 2026after the close$403.50M+21.2%$0.04Release
Q4 FY2025ended Dec 31, 2025Feb 25, 2026after the close$382.20M+17.4%–Release
Q3 FY2025ended Sep 30, 2025Nov 6, 2025after the close$363.80M+16.3%$0.00Release
Q2 FY2025ended Jun 30, 2025Aug 7, 2025after the close$345.30M+10.6%-$0.01Release
Q1 FY2025ended Mar 31, 2025May 7, 2025after the close$333.00M+10.9%$0.00Release
Q4 FY2024ended Dec 31, 2024Feb 27, 2025after the close$325.50M––Release
Q3 FY2024ended Sep 30, 2024Nov 7, 2024after the close$312.70M+18.9%-$0.02Release
Q2 FY2024ended Jun 30, 2024Aug 8, 2024after the close$312.30M+20.3%-$0.06Release
Q1 FY2024ended Mar 31, 2024May 9, 2024after the close$300.40M+18.9%-$0.06Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Current guidance

LifeStance Health's latest outlook for periods it has not reported yet, compared with what it said before

MetricPeriodGuidanceBeforeChangeGiven
total revenueGAAPQ4 FY2026$446.00M – $466.00M–NewNov 5, 2026
Adjusted EBITDAnon-GAAPQ4 FY2026$56.00M – $64.00M–NewNov 5, 2026
Center Marginnon-GAAPQ4 FY2026$149.00M – $163.00M–NewNov 5, 2026
full year revenueFY2026$1.69B – $1.73B$1.64B – $1.68BRaisedAug 6, 2026
revenueGAAPFY2026$1.74B – $1.76B–NewNov 5, 2026
Adjusted EBITDAnon-GAAPFY2026$242.00M – $250.00M–NewNov 5, 2026
Adjusted EBITDAnon-GAAPFY2026$215.00M – $235.00M$200.00M – $220.00MRaisedAug 6, 2026
Center Marginnon-GAAPFY2026$599.00M – $613.00M–NewNov 5, 2026
Center Marginnon-GAAPFY2026$570.00M – $594.00M$547.00M – $571.00MRaisedAug 6, 2026

Guidance vs results

The last range LifeStance Health gave before each report, against the figure it then reported. Full years add up the four quarters.

PeriodMetricGuidanceActualResult
Q3 FY2026Revenue$420.00M – $440.00M$455.90MAbove range
Q2 FY2026Revenue$405.00M – $425.00M$435.40MAbove range
Q1 FY2026Revenue$380.00M – $400.00M$403.50MAbove range
FY2025Revenue$1.41B – $1.43B$1.42BΣ4QWithin range
Q4 FY2025Revenue$368.00M – $388.00M$382.20MWithin range
Q3 FY2025Revenue$345.00M – $365.00M$363.80MWithin range
Q2 FY2025Revenue$332.00M – $352.00M$345.30MWithin range
Q1 FY2025Revenue$320.00M – $340.00M$333.00MWithin range
Q4 FY2024Revenue$302.50M – $322.50M$325.50MAbove range
Q3 FY2024Revenue$290.00M – $310.00M$312.70MAbove range
Q2 FY2024Revenue$297.00M – $315.00M$312.30MWithin range
Q3 FY2023Revenue$250.00M – $260.00M$262.90MAbove range

Guidance history

Every forecast LifeStance Health put in an earnings release, newest first

GivenMetricPeriodGuidanceChange
Nov 5, 2026Adjusted EBITDAFY2026$242.00M – $250.00MNew
Nov 5, 2026Adjusted EBITDAQ4 FY2026$56.00M – $64.00MNew
Nov 5, 2026Center MarginFY2026$599.00M – $613.00MNew
Nov 5, 2026Center MarginQ4 FY2026$149.00M – $163.00MNew
Nov 5, 2026revenueFY2026$1.74B – $1.76BNew
Nov 5, 2026total revenueQ4 FY2026$446.00M – $466.00MNew
Aug 6, 2026Adjusted EBITDAQ3 FY2026$49.00M – $59.00MNew
Aug 6, 2026Adjusted EBITDAFY2026$215.00M – $235.00MRaised
Aug 6, 2026Center MarginFY2026$570.00M – $594.00MRaised
Aug 6, 2026Center MarginQ3 FY2026$140.00M – $152.00MNew
Aug 6, 2026full year revenueFY2026$1.69B – $1.73BRaised
Aug 6, 2026total revenueQ3 FY2026$420.00M – $440.00MNew
May 6, 2026Adjusted EBITDAFY2026$200.00M – $220.00MRaised
May 6, 2026Adjusted EBITDAQ2 FY2026$50.00M – $60.00MNew
May 6, 2026Center MarginQ2 FY2026$135.00M – $147.00MNew
May 6, 2026Center MarginFY2026$547.00M – $571.00MRaised
May 6, 2026total revenueQ2 FY2026$405.00M – $425.00MNew
May 6, 2026revenueFY2026$1.64B – $1.68BRaised
Feb 25, 2026Adjusted EBITDAQ1 FY2026$39.00M – $45.00MNew
Feb 25, 2026Adjusted EBITDAFY2026$185.00M – $205.00MNew

Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.

Press releases

Releases LifeStance Health filed with the SEC as exhibits to Form 8-K or 6-K

  1. VP of Finance & Investor Relations
    Results
  2. Reimagining Mental Health Q3 2026 Earnings Presentation • November 5, 2026 Exhibit 99.2
    Results
  3. VP of Finance & Investor Relations
    Results
  4. Reimagining Mental Health Q2 2026 Earnings Presentation • August 6, 2026 Exhibit 99.2
    Results
  5. VP of Finance & Investor Relations
    Results
  6. Reimagining Mental Health Q1 2026 Earnings Presentation • May 7, 2026 Exhibit 99.2
    Results
  7. VP of Finance & Investor Relations
    Results
  8. Reimagining Mental Health Q4 2025 Earnings Presentation • February 25, 2026 Exhibit 99.2
    Results
  9. VP of Finance & Investor Relations
    Results
  10. Reimagining Mental Health Q3 2025 Earnings Presentation • November 6, 2025 Exhibit 99.2
    Results
  11. VP of Finance & Investor Relations
    Results
  12. Reimagining Mental Health Q2 2025 Earnings Presentation • August 7, 2025 Exhibit 99.2
    Results
  13. LIFESTANCE NAMES VAUGHN PAUNOVICH AS CHIEF TECHNOLOGY OFFICER
    Update
  14. VP of Finance & Investor Relations
    Results
  15. Reimagining Mental Health Q1 2025 Earnings Presentation • May 7, 2025 Exhibit 99.2
    Results

See a number that looks wrong?